We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ashwin Ananthakrishnan

Ashwin N. Ananthakrishnan MD

Assistant Professor of Medicine, Harvard Medical School; Medical Co-Director, MGH Crohn’s and Colitis Center, Boston, Massachusetts

Ashwin N. Ananthakrishnan completed his medical degree at the Jawaharlal Institute of Post-Graduate Medical Education and Research in India, graduating at the top of his class. In 2004, he followed up his MD with an MPH from the Johns Hopkins University School of Public Health again graduating at the top of his class and was selected to the Delta Omega public health honorary society. He subsequently completed his internal medicine residency and gastroenterology fellowship at the Medical College of Wisconsin before joining the Gastroenterology Unit at Massachusetts General Hospital in July 2010. He is currently an Assistant Professor of Medicine at Harvard Medical School and is medical co-director at the MGH Crohn’s and Colitis center. He has received research support from the AGA, ACG, and National Institutes of Health. He has over 100 original publications in leading academic journals including Gastroenterology, Gut, and the Annals of Internal Medicine. His research focuses on the epidemiology and outcomes of inflammatory bowel diseases including the role of genetics and the environment in disease pathogenesis and natural history. He is also on the editorial board for Gastroenterology, Clinical Gastroenterology and Hepatology, and Inflammatory Bowel Diseases as well as being an active member of the AGA, ACG, and CCFA.   

Disclosures

Disclosures: Dr. Ananthakrishnan has serviced on the scientific advisory boards for Abbvie and Cubist pharmaceuticals.

Recent Contributions to PracticeUpdate:

  1. MY APPROACH to Pregnancy and IBD